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Study objective: The present study evaluated the relationship between health
status (HS) and peripheral muscle histochemical characteristics in chronic
obstructive pulmonary disease (COPD), and identified selected independent
respiratory and extrapulmonary variables that predicted the HS of these patients.
Design: Cross-sectional study.
Setting: Outpatient respiratory clinic of a university hospital.
Patients and methods: We studied 29 patients (63710 yrs) with a forced expiratory
volume in 1 s (FEV1) of 39712%. All patients underwent vastus lateralis muscle
biopsies for histochemical analysis. They also had spirometry, arterial blood gas
analysis, body mass index (BMI), dyspnea determined with the MMRC scale and
responded to the St. George’s Respiratory Questionnaire (SGRQ) for HS assessment.
Results: SGRQ total score correlated with fiber type distribution. A stepwise
multiple regression identified three independent predictors of SGRQ total score:
type I fiber proportion, BMI, and FEV1; r ¼ 0:78 and r2 ¼ 0:61.
Conclusions: These results indicate that impaired HS in COPD is related to the
peripheral muscle changes characterized by less type I fibers proportion. The
findings argue in favor of an important contribution of the systemic consequences on
the HS in COPD independently from the airflow limitation severity, and help toElsevier Ltd. All rights reserved.
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limitation and SGRQ total score.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) has
been defined as ‘‘a disease state characterized by
airflow limitation that is not fully reversible. The
airflow limitation is usually both progressive and
associated with an abnormal inflammatory re-
sponse of the lungs to noxious particles or gases’’.1
Although not included in the definition it is clear
that apart from the pulmonary impairment, COPD is
associated with important systemic consequences
such as peripheral muscle dysfunction and wasting
that may contribute to limiting exercise capacity
and daily life activities. Probably the most exten-
sively studied extrapulmonary effects of COPD is
the peripheral muscle dysfunction, characterized
by a reduced proportion of type I fibers, and an
increase in type II fibers, as well as decreased
oxidative enzyme activity.2–8 Type I fibers are slow-
twitch fibers, develop a relatively small tension,
have increased oxidative capacity, and are resistant
to fatigue. Type IIb fibers are fast-twitch fibers,
develop high tensions, depend primarily on anae-
robic glycolytic metabolism, and are highly suscep-
tible to fatigue. Type IIa fibers are intermediate in
character. In COPD patients the increased propor-
tion of type II fibers is of type IIb in most studies,
but an increase in type IIa fibers with no change in
type IIb fibers has also been reported. This shift in
fiber proportion increases fatigability and reduces
muscle endurance.
Health status (HS) is known to be affected in
patients with COPD. The St. George’s Respiratory
Questionnaire (SGRQ) has become one of the
most widely used instruments for assessing HS in
these patients, because it is disease specific, and
has been translated and validated in several
languages.9,10
Despite the fact that HS in COPD has been used
extensively in descriptive and therapeutic evalua-
tion studies, the factors determining its values are
poorly understood. It is possible that in addition to
respiratory impairment, other conditions such as
the systemic manifestation of COPD may play an
important role. Because peripheral muscle function
may contribute to the reduced exercise perfor-
mance and physical activities in COPD, we hy-
pothesized that the different components of SGRQ
could be related with the degree of peripheral
muscle abnormalities in patients with COPD.Indeed, although few reports have shown a
significant correlation between skeletal muscle
strength and endurance with HS and physical
activity score in patients with COPD,11,12 no
previous study has evaluated the relationship
between HS with peripheral muscle structural
characteristics (fiber-type proportion, cross-sec-
tional area of the fibers, and capillarity).
We therefore designed this study to investigate
the relationship between the different domains of
SGRQ with peripheral muscle histochemical char-
acteristics in stable COPD.Methods
Subjects
We studied a random group of 29 COPD patients
(63710 yr) that consecutively assisted to the
pulmonary clinic of the Hospital Universitario de
Caracas, during a period of 3 months. COPD was
defined as a post-bronchodilator forced vital
capacity/forced expiratory volume in 1 s (FEV1/
FVC)o0.7,13 and a history of smoking 420 pack
years.
The patients were in clinically stable condition
defined as no acute exacerbation of COPD for 6
weeks prior to entry into the study, and receiving
optimal medical therapy without a regular use of
systemic corticosteroids.
Patients were excluded if they had asthma
defined as a 412% and 200ml reversibility of the
FEV1 after bronchodilators, or history of atopy. Also
excluded were patients with congestive heart
failure and those involved in regular exercise
training.
The committee on human research approved the
study and all the patients signed the informed
consent, and none refused to have the biopsy
performed.Pulmonary function test
The FEV1, FVC and FEV1/FVC were calcula-
ted according to the recommendations of the
American Thoracic Society.14 Normal values for
pulmonary measurements were taken from a
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Table 1 Anthropometric and spirometry data.
Variable Mean7SD Range
Age (yr) 63710 44–81
Height (cm) 16179 137–177
Weight (kg) 58717 34–102
BMI 21.975 15–36
FVC (% pred.) 69715 43–109
FEV1 (% pred.) 39712 17–73
FEV1/FVC (%) 45710 25–70
Definition of abbreviations: BMI: body mass index; FVC:
forced vital capacity; FEV1: forced expiratory volume in
1 s.
M. Montes de Oca et al.1802standard reference source.15 Arterial blood gases
were measured at rest while breathing room air.
Health status and dyspnea assessment
The HS was assessed with SGRQ, Spanish ver-
sion.9,10 This is a 50-item questionnaire that
evaluates three dimensions of the disease: symp-
toms (8-item), activity (16-item), and impact
(26-item). The score ranges from 0 to 100 for each
domain with higher values reflecting worse health
status. A trained interviewer administered this
questionnaire.
The degree of dyspnea was measured with the
Modified Medical Research Council (MMRC) dyspnea
scale.16 The body mass index (BMI) was determined
by dividing the weight in kilograms by the height in
meters2.
Skeletal muscle study
Muscle samples were taken from the vastus
lateralis part of the quadriceps femoris muscle,
with a Bergstro¨m needle.17 Briefly, after local
anesthesia with 2 cc of lidocaine 2%, a 5-mm skin
incision was performed and muscle samples were
obtained. The samples were divided in two parts.
One was embedded with OCTcompound (Tissue Tek II)
and frozen in isopentane cooled with liquid
nitrogen. Transverse 10 mm serial sections were
cut in a cryostat at 20 1C and mounted on cover
slips for adenosine triphosphatase (ATPase) staining
after alkaline (pH: 10.3) and acid (pH: 4.37 and 4.6)
preincubation.18 Capillaries were visualized by the
a-amylase-PAS reaction.19 Photomicrographs at a
final magnification of X200 were taken from these
sections and the fibers were identified by compar-
ison with the ATPase sections. An area of the
photograph was delimited, measured with a plani-
meter, and fibers and capillaries were counted to
calculate the mean cross-sectional area (CSA) of
the fibers, capillaries/mm2, and capillaries/fiber
ratio. Also, capillaries around each fiber type were
counted and the mean was expressed as capillary
contacts. All the fibers of one type were drawn
together, and the area was measured by planimetry
to calculate the mean area of each fiber type.
Statistical analysis
Data are presented as mean7SD. Pearson’s correla-
tion (r) was used to assess the relationship between
anthropometric variables, spirometry, PaO2, dys-
pnea, and skeletal muscle characteristics, with
SGRQ total score. Forward stepwise multipleregression analysis was used to determine the best
model that predict SGRQ total score, from selected
independent variables (FEV1% predicted, BMI, the
type I fiber proportion, and MMRC scale) in patients
with stable COPD. The acceptable level of statis-
tical significance for the tests was a probability
value of less than 0.05 (Po0:05).Results
The mean values for physical characteristics and
spirometry of the enrolled patients are detailed in
Table 1. The patients had severe airflow obstruc-
tion, as shown by a mean FEV1, and FEV1/FVC of
39712, and 46710% predicted, respectively. The
results of MMRC dyspnea scale and SGRQ scores are
shown in Table 2. As expected severe impairment
was observed in symptoms, daily living activities,
impact components and total SGRQ scores.
The histochemical characteristics of the periph-
eral muscle are shown in Table 3. The patients had
an altered fiber-type distribution as shown by a
shift towards a higher proportion of type II fibers.
The main correlations between SGRQ total score
with physical characteristics, spirometry, PaO2,
skeletal muscle characteristics are shown in Table 4.
The results indicate that SGRQ total score corre-
lated inversely with airway obstruction and hypox-
emia, as well as directly with body BMI. Figure 1
shows the inverse relationship between the SGRQ
total score with type I fiber proportion. No signifi-
cant correlations were found between SGRQ total
score and dyspnea scale.
Stepwise multiple regression analysis was per-
formed to determine the best model that predicts
SGRQ total score. The type I fiber proportion was
the single best predictor; after this only BMI, and
the degree of airflow obstruction (FEV1% predicted)
entered in the model, which explained 61% of the
SGRQ total score variability (Table 5).
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Table 2 Dyspnea scale and SGRQ scores.
Variable Mean7SD Range
MMRC scale 2.270.7 1–4
SGRQ symptom 46723 7–90
SGRQ activity 66716 35–87
SGRQ impact 37717 8–92
SGRQ total score 4779 20–58
Definition of abbreviations: MMRC: Modified Medical Research
Council; SGRQ: St. George’s Respiratory Questionnaire.
Table 3 Skeletal muscle characteristics.
Variable Mean7SD Range
Fiber-type proportion (%)
Type I 36711 22–68
Type IIa 4079 25–59
Type IIb 24710 4–42
Mean CSA (mm2) 529171430 3482–8109
CSA Type I (mm2) 666872156 3121–11446
CSA Type IIa (mm2) 500771589 2693–8891
CSA Type IIb (mm2) 396671454 1747–8288
Capillaries/fiber ratio 1.4270.30 0.96–2.0
Number of capillaries/
mm2
281749 176–350
No. of capillary contacts
Type I 4.571.0 2.5–6.6
Type IIa 3.670.9 2.3–5.2
Type IIb 3.170.8 1.7–4.5
Definition of abbreviations: CSA: cross-sectional area.
Table 4 Main correlations with SGRQ total score.
Variable r P-level
SGRQ (total)—BMI 0.39 o0.05
SGRQ (total)—FEV1 (%) 0.54 o0.01
SGRQ (total)—FEV1/FVC (%) 0.59 o0.01
SGRQ (total)—PaO2 (mmHg) 0.46 o0.05
SGRQ (total)—Type I (%) 0.59 o0.01
Definition of abbreviations: SGRQ: St. George’s Respira-
tory Questionnaire; BMI: body mass index; FVC: forced
vital capacity; FEV1: forced expiratory volume in 1 s.
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Figure 1 Correlation between SGRQ total score with type
I fiber proportion (Po0:01).
Table 5 Stepwise multiple regression for SGRQ
(total score).
Variable b B t P-level
Type I (%) 0.39 0.49 2.3 0.03
BMI 0.33 0.73 2.2 0.04
FEV1 (%) 0.37 0.33 2.2 0.04
r ¼ 0:78
r2 ¼ 0:61
Definition of abbreviations: SGRQ: St. George’s respira-
tory questionnaire; BMI: body mass index; FEV1: forced
expiratory volume in 1 s.
Peripheral muscle composition and health status 1803Discussion
In patients with COPD, several studies have shown
considerable modifications in the skeletal muscle
histochemical characteristics. In general, biopsies
of the quadriceps muscle have shown a reducedproportion of type I fibers and an increase in the
proportion of type II fibers as compared with
normal individuals. This change in fiber proportion
reduces muscular oxidative capacity increasing
fatigability and reducing muscle endurance. The
results of the present study indicate that COPD
patients had an altered fiber-type distribution as
shown by a shift towards a higher proportion of
type II fibers with respect to reported normal
values (type I 56.773.4% and type II 43.273.4%).4
The present study also demonstrates that in
COPD patients SGRQ total score correlates with
peripheral muscle fiber type composition. The
results suggest that worse HS is associated with
less proportion of type I fibers which are funda-
mentally oxidative. This result indicates that
pathophysiological changes in peripheral muscles
may influence SGRQ total score independent of the
degree of airflow limitation.
The stepwise multiple regression analysis showed
that the best predictive model for SGRQ total score
in stable COPD integrated the type I fibers propor-
tion, the FEV1, and BMI. Among these factors the
type I fiber proportion showed a stronger associa-
tion than the FEV1.
During the last decade, the consequences of
COPD on HS have become an area of increasing
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in these patients to evaluate the benefits, side
effects, and cost of different treatments. Interest-
ingly, a recent study has shown that HS can help
predict mortality in COPD.20 The SGRQ is a disease-
specific questionnaire that has been adapted and
validated in Spanish. This test evaluates three
dimensions of the disease: symptoms, activity, and
impact. The symptoms component contains items
concerned with the respiratory symptoms, their
frequency, and severity. As the name implies the
activity domain is concerned with physical activ-
ities that either cause or are limited by breath-
lessness. The impact component which covers a
range of aspects concerned with social functioning
and psychological disturbances resulting from air-
way disease. Even though this instrument has
proven extremely useful in the description of
population with COPD and that it has enjoyed
extensive use in the evaluation of response to
therapy, there is surprisingly limited information
regarding the factors that affect HS in COPD.
Different studies have shown that HS question-
naires21–26 correlate only moderately with the most
widely used clinical indicator of severity in COPD
the FEV1.
21–24 Hajiro et al.21 compared three
different HS questionnaires in COPD patients
(SGRQ, the breathing problems questionnaire, and
the chronic respiratory disease questionnaire or
CRQ). They found that these questionnaires had
significant but weak correlations (rs ¼ 0:24 to
0.36) with some physiologic variables (FVC, FEV1,
and diffusing capacity), and mild to moderate
correlations with exercise capacity and assessment
of dyspnea, anxiety, and depression.21 Tsukino
et al.22 studied the physiologic factors that
influence HS in COPD patients. They found that HS
was partly determined by airflow limitation, diffus-
ing capacity, smoking history, and age. On the other
hand, Ketelaars et al.23 found that the FEV1, the
12min walking test and the coping strategies were
the best predictors of HS. Although some of these
studies have used different HS questionnaires the
results could be applicable to the SGRQ due to the
reported significant relationship among the differ-
ent tests.21 Taken together, these findings suggest
that HS probably expresses the respiratory as well
as the systemic consequences of this complex
disease.
One of the most extensively studied systemic
consequences of COPD is that of the peripheral
muscle dysfunction observed in many of these
patients. Different reports have shown that a
significant proportion of patients develop periph-
eral skeletal muscle wasting and weakness that
appear to be associated with important conse-quences such as exercise intolerance, daily activ-
ities limitation, and reduced peripheral muscle
strength.27,28 Furthermore, some investigators
have found an association between reduced muscle
mass and survival in COPD patients, independent of
a reduction in FEV1.
29
Few previous studies have evaluated the rela-
tionship between HS with peripheral muscle
strength and endurance in COPD patients.11,12
Serres et al.12 found a significant correlation
(r ¼ 0:60) between the physical activity score
obtained from a questionnaire with an endurance
test of the quadriceps. In addition, Toral Marin
et al.11 assessed the peripheral muscle strength by
measuring the maximum load of upper and lower
extremities and found that it was related to
maximum workload and some aspects of HS.
To our knowledge, no previous study has corre-
lated HS with the histochemical and morphological
characteristics of the peripheral muscle in COPD.
The results of the present study show an inverse
correlation between SGRQ total score with type I
fiber proportion. This result indicate that the
abnormal HS reported by COPD patients is asso-
ciated with changes in the peripheral muscle
characterized by less proportion of type I fibers
which are fundamentally oxidative. It is possible to
speculate that the activity and impact components
of SGRQ involve some aspects of the patient’s
ability to work and perform daily life activities that
could be markedly affected by the compromise of
peripheral muscle capacity to perform their work.
In addition, the multiple regression analysis
identified three independent predictors of SGRQ
total score in stable COPD patients: the type I fibers
proportion, airflow limitation, and BMI. Together
they explain 61 percentage of its variability.
Probably the most important finding in the model
is the predominant contribution of the systemic
consequences over the respiratory component. The
rest of the variability of HS could be explained by
the influence of other factors not evaluated in the
present study such as hyperinflation, exercise
capacity, and the emotional status.
Despite the fact that malnutrition has been
associated with different deleterious effects in
COPD patients,30,31 one study has reported that
overweight COPD patients had greater impairment
in impact and total SGRQ scores compared to
normal weight patients.32 The results of our study
support the concept that increased BMI is asso-
ciated with worse HS. These results point out the
need to further evaluate the influence of BMI on
outcome in patients with COPD.
There were some limitations to our study. First,
the number of patients is relatively small compared
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However, 29 is the largest number of COPD ever
reported with peripheral muscle biopsy and HS
assessment. In addition, the strong relationship
between fiber composition and the HS question-
naire provides a rational link between the associa-
tions. Second, the importance of peripheral muscle
composition is further highlighted by the logistic
regression results. Third, biopsies of other periph-
eral muscles such as the upper extremity or
intercostals were not sampled. The relationship
between the composition of those muscles and HS
could differ and remain to be studied.
In summary, the present study shows that
impaired HS in patients with COPD is accompanied
by fewer fibers with predominant oxidative capa-
city (type I fibers) in the peripheral skeletal
muscle. The multiple regression model shows HS
in COPD is best predicted by the degree of
involvement of the type I fiber proportion, the
degree of airflow limitation, and nutritional status.
These results argue in favor of an important
contribution of the systemic consequences on the
HS in stable COPD independently from the airflow
limitation severity, and help to explain the ob-
servation of the poor correlation between the
degree of airflow limitation and SGRQ total score.Acknowledgment
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